Combivir

This page contains recent news articles, when available, and an overview of Combivir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

2009 Big Pharma DOTY: GSK, Pfizer Join Hands in HIV  -  ‎Dec 21, 2009‎
At the same time, GSK wins a bunch of pipeline products from Pfizer (great, since Combivir's heading for genericization), and Pfizer benefits from GSK's ... The IN VIVO Blog (blog)

Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015 ...  -  ‎Dec 15, 2009‎
Viread 9.3.4 Isentress 9.3.5 Trizivir 9.3.6 Kaletra 9.3.7 Reyataz 9.3.8 Combivir 9.3.9 Epzicom/Kivexa 9.3.10 Sustiva Franchise 9.4 Competitive Profiling ... IT News Online

In-depth analysis of unmet needs, drivers and barriers that impact global HIV ...  -  ‎Dec 10, 2009‎
This is primarily due to the patent expiry of major drugs such as Sustiva and Combivir in 2012. However the impact of patent expiration will be offset by ... News-Medical.net

Combivir: The HIV Drug in Hasan's Shoe Box  -  ‎Nov 12, 2009‎
Stuffed into a shoe box and left in the laundry room, the collection included vitamins and an old bottle of an anti-HIV drug called Combivir. ... TIME

Hasan Proclaimed Himself "Soldier of Allah"  -  ‎Nov 12, 2009‎
Curiously, officers found a half-empty bottle of Combivir in Hasan's house. Combivir is a drug used to treat HIV. Hasan was prescribed the drug in 2001 ... The New American

Generic Name: Lamivudine/Zidovudine  -  ‎Nov 11, 2009‎
Combivir (generic name: Lamivudine/Zidovudine) is used, alone or with other medicines, to slow down the progression of human immunodeficiency virus (HIV) ... Pattaya Daily News

Drug firms' collaboration pools HIV treatments  -  ‎Nov 3, 2009‎
ViiV will inherit GSK's agEing portfolio of HIV medicines, including Combivir, which will lose its patent protection in three year's time, and Pfizer's ... Independent

Coalescing purpuric plaques  -  ‎Nov 10, 2009‎
His medications included Combivir (lamivudine/zidovudine) and nelfinavir. A biopsy revealed increased spindle cells with vascular slits. ... Clinical Advisor

Generic Name: Tenofovir, emtricitabine  -  ‎Nov 11, 2009‎
Do not take Truvada if you are already taking Atripla, Combivir (lamivudine/zidovudine), Emtriva, Epivir or Epivir-HBV (lamivudine), Epzicom (abacavir ... Pattaya Daily News

Glaxo-Pfizer tie-up opens new era in Aids battle  -  ‎Oct 31, 2009‎
GSK was at the forefront of breakthroughs in HIV and Aids treatments in the late 1980s and 1990s with anti-virals such as Retrovir, Epivir and Combivir, ... Telegraph.co.uk

'Thiếu tá thảm sát' ở Mỹ đối mặt án tá»­ hình  -  ‎Nov 13, 2009‎
Ngoài ra, h� cũng tìm thấy nửa l� thuộc Combivir trong nhà Hasan. Combivir là một loại thuốc dùng để đi�u trị HIV. Hasan là bác sĩ tâm lý tại Fort Hood. ... VNExpress

è¼?瑞+葛蘭素å?²å…‹ 抗愛滋  -  ‎Nov 1, 2009‎
...葛蘭素å?²å…‹åœ¨1980年代與1990年代末期研發出立妥å¨?(Retrovir)ã€?速汰滋(Epivir)與å?¡è²?滋(Combivir)等藥物,å?¯æœ‰æ•ˆæ¸›ç·©ç—…狀,被喻為å°?抗愛滋病與HIV病毒的é‡?大çª?ç ´ ... 聯合新聞網

Glaxo und Pfizer gründen Joint Venture  -  ‎Nov 3, 2009‎
GSK steuert die Kombinationsmittel Combivir, Kivexa, und Trizivir sowie die Monopräparate Epivir, Telzir, Retrovir ud Ziagen bei. ... apotheke-adhoc

GSK retracts AIDS drug Combivir's patent appeal  -  Aug 21, 2006
The company had filed the patent application for Combivir, which is a ... Combivir is a widely-used fixed dose combination and used preferably in projects ... Business Standard

HIV drug combinations better protect babies in Third World: study  -  Feb 25, 2005
Scientists add Combivir to nevirapine, a cheap and highly effective AIDS drug widely used to ... Combivir contains two HIV drugs called the AZT and 3TC. ... 新�网

Gilead's Truvada Seen Driving Switchers From Combivir  -  Dec 19, 2005
FBR Equity Research analyst Jim Reddoch maintained an "outperform" rating and $70 price target on Gilead Sciences (nasdaq: GILD - news - people ) after data ... Forbes

California firm challenges Glaxo's dominance of AIDS drug market.  -  Jan 19, 2006
In a statement, GSK said that Combivir has been evaluated in more than 50 studies involving more than 18000 patients, and is found to be effective and safe. ... Free with registration - News & Observer - AccessMyLibrary.com

… Corporate News - Gilead meldt gegevens overstap van Combivir naar ...  -  Oct 29, 2007
..."Data from this study indicate that patients on long-term Combivir therapy without ... Combivir, previously recommended as a first-line treatment option, ... Netherlands Corporate News - Netherlands Corporate News (persbericht)

Gilead's Truvada Seen Superior To GSK's Combivir  -  Nov 18, 2005
RBC Capital Markets maintained an "outperform" rating on Gilead Sciences (nasdaq: GILD - news - people ) after the drug firm reported positive trial results ... Forbes

Starting or Switching: Truvada Outpaces Combivir in Studies  -  Jul 26, 2007
...by Tim Horn. Researchers have reported extended follow-up data from a clinical trial comparing two pairs of nucleoside reverse transcriptase inhibitors ... AIDSmeds.com HIV/AIDS Treatment News

Glaxo's patent on AIDS drug opposed  -  Mar 31, 2006
Combivir is the backbone of AIDS therapy and is used in the first-line of treatment, ... Combivir is a fixed-dose combination of two existing AIDS drugs ... Hindu Business Line

Anti-AIDS drug for newborns gets boost  -  Apr 10, 2005
New research suggests that nevirapine works best when given with a drug called Combivir. Combivir dramatically reduces the likelihood that single-dose ... USA Today

FDA Warns of HIV Drug Tampering  -  Apr 11, 2007
Combivir tablets are white and engraved with "GX FC3" on one side of the table. Ziagen tablets are yellow and are engraved with "GX 623" on one side of the ... WebMD

Researchers find better HIV medication  -  Jan 19, 2006
The therapy was compared to the combination of zidovudine, lamivudine (AZT and 3TC, or Combivir), and efavirenz. One-year use of the therapy has also led to ... 新�网

Intl AIDS Society-USA recommends 3 GSK HIV treatments for …  -  Aug 14, 2006
...'We are pleased to see that the guidelines committee has recognized Combivir, Epzicom, and Lexiva as important treatment options for patients with HIV,' ... Forbes

Californian court turns up pressure on Glaxo chief  -  Apr 5, 2005
It is being forced to provide details about clinical trials of Combivir, ... Both of Glaxo's bestselling Aids drugs, Combivir and Trizivir, contain AZT. ... Telegraph.co.uk

Kolkata group against GSK's AIDS patent  -  Aug 8, 2006
Drug major GlaxoSmithKline's plan to patent its HIV/AIDS drug - Combivir - in ... The NGO claimed that Combivir, a fixed-dose combination of two essential ... Rediff

Aids drugs to Africa rebranded in drive to beat racket  -  Feb 21, 2005
The company is preparing to switch to new versions of Combivir and ... A month's supply of Combivir costs £318.60 in the UK, but is sold for £10 in Africa. ... Times Online

… From Gilead's Study 934 Comparing Truvada(R) to Combivir(R) Both...  -  Jul 23, 2007
The most common cause of discontinuation in the Combivir/Sustiva arm was anemia/hemoglobin decrease (14 vs. 0 patients in the Truvada/Sustiva arm), ... RedOrbit

Long-Term Data on Combivir vs. Viread/Emtriva  -  Dec 15, 2006
...by Tim Horn. Researchers have published extended follow-up data from an important clinical trial comparing two pairs of nucleoside reverse transcriptase ... AIDSmeds.com HIV/AIDS Treatment News

GSK poised to act against illegal diversion of AIDS drugs  -  May 23, 2005
...including packaging, labelling and a red coating on the Combivir and Epivir antiretroviral tablets it supplies at cost to the poorest countries. ... Forbes

GSK Reports Combivir and Ziagen Tampering  -  Apr 2, 2007
GlaxoSmithKline has issued a letter to healthcare providers and community educators regarding apparent third-party tampering that caused misbranding of ... AIDSmeds.com HIV/AIDS Treatment News

New HIV Regimen Outperforms Gold Standard  -  Jan 18, 2006
AZT and 3TC are also formulated as a single pill, Combivir, but are taken twice daily, while Sustiva is taken once daily. Dr. Gallant said the advent of the ... CNN

Pfizer HIV Drug Shows Promise  -  Oct 29, 2008
More than two-thirds of HIV patients taking Pfizer's Selzentry and GlaxoSmithKline's Combivir had the viral load in their blood suppressed to undetectable ... FDA news - FDA news (subscription)

California; Gilead Posts 37% Gain in Earnings; Cheesecake Factory's …  -  Apr 20, 2005
Truvada competes with Combivir and with GlaxoSmithKline's Epzicom medicine. About 60% of newly diagnosed HIV patients who begin treatment in the U.S. are ... Pay-Per-View - Los Angeles Times - ProQuest Archiver

Rilpivirine (TMC-278)  -  Sep 24, 2008
The 96-week data indicate that when combined with Truvada or Combivir, rilpivirine has comparable results to the leading NNRTI, efavirenz. ... NAPWA

Isolated Case of Counterfeit Combivir on the Market  -  Apr 12, 2007
GlaxoSmithKline is informing health care professionals of an incident of misbranding of Ziagen (abacavir sulfate) as Combivir (lamivudine/zidovudine). ... Facts and Comparisons

Combivir.(Used to fight the human immunodeficiency virus )(Drug …  -  Dec 1, 2005
Combivir is used to fight the human immunodeficiency virus (HIV) that causes AIDS. It is a combination product containing the two AIDS drugs, ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Business News in Brief  -  Aug 22, 2006
GlaxoSmithKline PLC has withdrawn its patent application for the AIDS drug Combivir in India. Glaxo has one of its US headquarters in Philadelphia. ... $2.95 - Philadelphia Inquirer - NewsBank

Learn about Epoetin Alfa Injection from Consumer Reports Health.  -  Jan 9, 2008
Epoetin alfa is also used to treat anemia caused by chemotherapy (medications to treat cancer) or zidovudine (AZT, Retrovir, in Trizivir, in Combivir), ... consumerreports.org

Tenofovir / FTC 'non-inferior' to Combivir after one year, Gilead...  -  Feb 3, 2005
Gilead Sciences announced preliminary 48-week results of its Study 934 today, showing that the combination of its nucleotide analogue tenofovir (Viread) and ... Aidsmap

Mmegi Online ::> news we need to know  -  Jan 24, 2006
Since 1998, zidovudine and lamivudine have been available in a single-pill formulation called Combivir, which is prescribed as one pill taken twice daily. ... Mmegi Online

Q4 2006 Gilead Sciences Earnings Conference Call - Part 2.  -  Jan 3, 2007
And importantly, switches from Combivir accounted for 15% of the switches to ... That said, 30000 patients remain on a Combivir plus Sustiva regimen, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

IAC: Is Kaletra Monotherapy Possible?  -  Aug 21, 2006
Approximately 79% had viral loads below 400 at week 24 in the Kaletra monotherapy group, compared to 77% in the Kaletra/Combivir group. ... AIDSmeds.com HIV/AIDS Treatment News

FDA approves AIDS drug  -  Jul 9, 2005
A generic version of GlaxoSmithKline Plc's combination AIDS drug Combivir won tentative US approval on Friday for use under US President George W. Bush's ... TVNZ

Truvada/Sustiva cuts viral load vs Combivir/Sustiva.  -  Aug 6, 2007
Truvada/Sustiva cuts viral load vs Combivir/Sustiva. USA-based Gilead Sciences presented strong 144-week data from an ongoing clinical trial comparing a ... $9.94 - Pharma Marketletter - Alacra Store

Fat loss associated with Combivir but not Truvada  -  Jan 23, 2006
Individuals who took a year of anti-HIV treatment consisting of efavirenz (Sustiva) with tenofovir and FTC (Truvada) had significantly more limb fat than ... Aidsmap

Aurobindo Pharma gets tentative USFDA nod for generic AIDS drug  -  Jul 13, 2005
The drug is the first generic version of GlaxoSmithKline Plc's combination AIDS drug Combivir. The company said the USFDA approval would enable it to ... Hindu Business Line

Gilead's Atripla, Lower Costs Provide Lift To First Quarter  -  Apr 23, 2007
IMS Health showed that, through the end of last year, Combivir patients ... Gilead is pushing Atripla hard over Combivir, waving results from Study 934, ... BioWorld Online - BioWorld Online

New data reinforce efficacy of Trizivir® alone in treatment-naïve HIV...  -  Sep 28, 2006
The ACTION study — short for Atazanavir, Combivir, Trizivir in Only Naïve Patients ... Trizivir and Combivir are two of GlaxoSmithKline's fixed dose ... webwire.com

Netherlands Corporate News - Voorbereidende 24-weekse data betreft …  -  Nov 17, 2005
At study entry, all patients were to have received Combivir for at least eight ... Eighty-nine percent of patients had taken Combivir for longer than one ... Netherlands Corporate News - Netherlands Corporate News (persbericht)

TMC278 Data at 48 Weeks Look Promising  -  Mar 2, 2007
Investigators were allowed to select either coformulated lamivudine/zidovudine ( Combivir , 76%) or coformulated tenofovir/emtricitabine ( Truvada , 24%), ... Medscape

After Glaxo patent, it is Novartis' turn  -  Aug 24, 2006
MUMBAI: The success of activists in forcing GlaxoSmithKline to withdraw the patent application for its HIV/AIDS drug combivir in India is now spurring on ... Times of India

Less side effects with switch from Combivir to Truvada.  -  Nov 5, 2007
US drugmaker Gilead Sciences says that 48-week data from a Phase III trial evaluating virologically-suppressed HIV patients who switched from treatment with ... $4.95 - Pharma Marketletter - ECNext

Combivir (zidovudine + lamivudine)  -  Mar 1, 2008
Combivir es un medicamento anti-VIH que pertenece a la categoría de los inhibidores nucleósidos de la transcriptasa reversa (INTR). Combivir evita que el ... AIDSmeds.com HIV/AIDS Treatment News

Business News Glaxo backs Russian HIV/Aids crusade  -  Sep 16, 2006
Glaxo will supply more than 90000 treatment packs of its drugs - Combivir, Epivir and Ziagen - to the Russian Government by the end of 2006. ... WalesOnline

ICAAC: Switching from Combivir to Truvada has benefits for treatment-...  -  Jan 12, 2006
Switching from Combivir (AZT [zidovudine] and 3TC [lamivudine]) to Truvada (tenofovir and FTC [emtricitabine]) increases the chances of a patient achieving ... Aidsmap

ICAAC: Trizivir vs. Reyataz/Combivir  -  Oct 3, 2006
...by Tim Horn. October 3, 2006 (AIDSmeds)—A new study suggests that 48 weeks of treatment with Trizivir® is comparable to a protease inhibitor-based regimen. ... AIDSmeds.com HIV/AIDS Treatment News

Truvada combo a no go?  -  Aug 22, 2005
Commonly used in first-line therapy, Combivir has experienced steady growth since ... “Comparative trials of Combivir, Truvada and Epzicom have demonstrated ... ICIS

Phase 3 Efficacy and Safety Data for Novel CCR5 Antagonist Maraviroc ...  -  Jul 27, 2007
Overall, 721 HIV-positive patients (29% female) were randomized to Combivir® (zidovudine/lamivudine) with efavirenz or maraviroc. ... DG News

Combivir, un'associazione di Lamivudina e Zidovudina, nel trattamento...  -  Apr 29, 2008
Martedì 29 Aprile 2008 - Combivir è un farmaco antivirale, contenente i principi attivi Lamivudina ( 150 mg ) e Zidovudina ( 300 mg ). ... XagenaSalute

Gilead HIV Drug Combo Beats GSK Rival in Phase III Trial  -  Jan 20, 2006
Both Truvada and Combivir are widely used fixed-dose combination medicines from the nucleoside reverse transcriptase inhibitor (NRTI) class of ... RedOrbit

Gilead Sciences at NASDAQ 16th Investor Program Conference - Part 1.  -  Dec 8, 2005
We have also now gone head-to-head with Combivir with the Truvada trial. ... We were able to show we had statistical superiority to Combivir. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Gilead Sciences at Morgan Stanley Global Healthcare Unplugged …  -  May 3, 2006
So the Truvada patients remained healthier versus the combivir patients in ... Or do you think there's going to be a difference because combivir is maybe a ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Patently unfair  -  Sep 18, 2006
Because the two antiretrovirals in Combivir were invented before 1995, ... Combivir is just the tip of the iceberg: India's patent offices are set to ... CNNMoney.com

Gilead Sciences at Thomas Weisel Partners Healthcare Conference - …  -  Sep 8, 2005
One place where the growth is is Combivir. As you see there are a large number of ... The revenues from Combivir worldwide last year were over 1 billion. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

XIV International HIV Drug Resistance Workshop: preventing mother-to-...  -  Jun 22, 2005
Single dose nevirapine combined with a short-course of combivir for prevention ... Short-course Combivir (CBV) single dose nevirapine reduces but does not ... Aidsmap

Gilead Buying Rest Of Corus; $365M Plus Lawsuit Payout  -  Jul 21, 2006
Atripla could draw patients away from London-based GlaxoSmithKline plc's Combivir, which consists of lamivudine and zidovudine. (See BioWorld Today, July 13 ... BioWorld Online - BioWorld Online

Gilead Is Nothing to Sneeze At  -  Oct 19, 2005
Results of a study comparing the effectiveness of Combivir and Truvada in the same patients will be released in December at the Interscience Conference on ... Smartmoney.com

Fourth Quarter and 2005 Year-End Gilead Sciences Earnings Conference …  -  Jan 3, 2006
Truvada continued to pull away from Combivir in new prescriptions during the fourth quarter of 2005, and as of the week ended January 13th, 2006, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

CROI: Saquinavir-based combination prevents mother-to-child HIV …  -  Feb 22, 2006
The investigators compared these findings to a cohort of 47 women treated with 1250mg nelfinavir and Combivir twice a day for the same period. ... Aidsmap

… TRUVADA BETTER AT SUPPRESSING HIV THAN GSK'S COMBIVIR  -  Nov 22, 2005
All patients had been taking Combivir for at least eight weeks prior to switching drugs. All of the patients also were taking Bristol-Myers Squibb's Sustiva ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones

New Data Reinforce Efficacy of Abacavir Sulfate/Lamivudine/Zidovudine...  -  Oct 12, 2006
The ACTION study -- short for Atazanavir, Combivir, Trizivir in Only Naive Patients ... Trizivir and Combivir are two of GlaxoSmithKline's fixed-dose ... DG News

FDA approves generic drug regimen.(Global HIV/AIDS)  -  Jan 31, 2005
One of Aspen's pills, which combines the drugs lamivudine and zidovudine, is a version of the Combivir tablets manufactured by GlaxoSmithKline. ... Free with registration - Medicine & Health - AccessMyLibrary.com

Schering-Plough Discontinues Phase II Study of Vicriviroc in Treatment...  -  Oct 28, 2005
This decision was due to a return of detectable virus in some patients late in therapy compared to the control regimen of Combivir and Sustiva, ... $4.95 - PR Newswire - ECNext

Treatment breaks: an individual perspective  -  Apr 27, 2006
...“I'd been on a combination of nevirapine and Combivir for several years and I was worried about the long-term effects of the AZT in the Combivir. ... NAPWA

Number of Pills Affects Adherence to HIV Treatment Regimens  -  Nov 30, 2005
Mean adherence was higher for patients taking COMBIVIR (85 percent) compared ... "Fixed-dose combinations like COMBIVIR can reduce treatment complexity when ... RedOrbit

Gilead's Tuvada outperforms GSK's Combivir in trials.(GlaxoSmithKilne)...  -  Nov 28, 2005
USA-based drugmaker Gilead Sciences says that preliminary data from a recent trial shows that HIV patients who switched to Truvada (emtricitabine and ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

… Study 934 Comparing Viread(R) and Emtriva(R) to Combivir(R) Both...  -  Aug 14, 2006
Patients in the comparator arm received Combivir twice daily and Sustiva 600 mg once daily. At study entry, patients had not previously received ... Free with registration - Business Wire - AccessMyLibrary.com

ARVs causing side effects phased out  -  Sep 28, 2008
We are now giving those with complaints alternatives like Combivir and Atripla as the first ... “We are now getting Combivir as the first line of treatment. ... New Vision

GSK to sell cut price HIV/Aids drugs to Russia  -  Sep 15, 2006
More than 90000 treatment packs of the anti-retroviral treatments Combivir, Epivir and Ziagen will be supplied to Russia by the end of this year. ... Hays Pharma

Gilead scores European OK for HIV drug  -  Feb 23, 2005
...indications are it is making inroads against GlaxoSmtihKline's Combivar. Combivir is a twice-daily combination of the drugs zidovudine and lamivudine. San Francisco Business Times

Pharmasset receives milestone after positive HIV drug trial  -  Aug 24, 2005
...such as those contained in Combivir and Truvada. Currently, physicians have limited options for patients once the M184V mutation appears. ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones

vicriviroc maleate Schering Plough discontinued, Europe, Canada (HIV ...  -  Nov 7, 2005
...phase II trial of vicriviroc maleate in combination with lamivudine/zidovudine (COMBIVIR) in treatment-naive HIV-infected patients. The study, which had ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Gilead Expands Global Access Program for HIV Therapies to Include …  -  Mar 16, 2005
E[acute accent]Truvada should not be used with Emtriva or Viread, or other drugs containing lamivudine, including Combivir(R), Epivir(R), $4.95 - Business Wire - ECNext

US Food and Drug Administration (FDA) Approves ATRIPLA(TM) ( …  -  Jul 12, 2006
This difference largely results from the higher number of discontinuations in the Combivir/SUSTIVA group due to adverse events (9% vs. ... Free with registration - PR Newswire - AccessMyLibrary.com

Updated HIV Treatment Guidelines Now Include Three GSK HIV …  -  Aug 13, 2006
The guidelines also support the use of COMBIVIR as a first-line therapy based on the ... INDICATION COMBIVIR is indicated in combination with other ... Free with registration - PR Newswire - AccessMyLibrary.com

Maraviroc confirma una mayor tasa de eficacia en pacientes con VIH...  -  Oct 27, 2008
Los resultados del estudio MERIT ES, mostraron que los pacientes tratados con Celsentri® (maraviroc) en combinación con Combivir® (zidovudina/lamivudina) ... acceso.com

Mmegi Online ::> news we need to know  -  Oct 6, 2005
The products affected are combivir, retrovir and trizivir. ... General Manager of Delta Pharmacies, one of the dealers in combivir in Botswana, ... Mmegi Online

Foreign Drugs Approved For Anti-AIDS Program  -  Jan 26, 2005
The Aspen package includes a generic version of Combivir and a third drug ... The price of Combivir in the United States is around $19 per person per day or ... Washington Post

Piden mayor castigo por incumplir abasto de fármacos  -  May 10, 2007
Respecto al desabasto de antirretrovirales ocurrido el año pasado, como el fármaco Combivir, producido por el laboratorio Glaxo Smith Kline (GSK), ... La Jornada - La Jornada (México)

IAS: New Antiretroviral Regimen Superior to Standard Treatment  -  Jul 27, 2005
..."We can say that the FTC-tenofovir regimen is superior to the Combivir regimen," ... He said that not only did the new regimen outperform the Combivir-based ... MedPage Today

HIV: An ever-changing epidemic.  -  Aug 10, 2005
..."Indeed, even older flagship products such as Combivir are under threat, ... "Comparative trials of Combivir, Truvada and Epzicom have ... $4.95 - M2 Presswire - ECNext

Gilead reports 48-wk data from HIV study.(Brief Article)  -  Feb 14, 2005
Similarly, 80% of subjects in the Truvada arm achieved and maintained HIV RNA of less than 50 copies/mL compared to 71% in the Combivir group (p=0.027; ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

HIV: an ever-changing epidemic  -  Aug 12, 2005
Indeed, even older flagship products such as GlaxoSmithKline's Combivir are ... Comparative trials of Combivir, Truvada and Epzicom have demonstrated the ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones

GSK withdraws Trizivir patent application 'in public interest'  -  Oct 10, 2007
In Glaxo's case, it created Combivir, the two-drug combination consisting ... As a result, Glaxo's Combivir drove down demand for older, single medications. ... Livemint

Halverer prisen for HIV-medisin  -  Feb 10, 2005
Selskapet, som er verdens største produsent av HIV/AIDS-medisiner, kunngjorde mandag at prisen på den mest brukte medisinen Combivir, nå er mellom seks og ... Aftenposten

Article: Foreign Drugs Approved For Anti-AIDS Program; Decision Means...  -  Jan 26, 2005
The Aspen package includes a generic version of Combivir and a third drug ... The price of Combivir in the United States is around $19 per person per day or ... Pay-Per-View - Washington Post - HighBeam Research

Press Release: Simplicity is the Key to Survival in the HIV Market...  -  Nov 15, 2005
Even older flagship products such as Combivir are now under threat. This report provides an examination of drivers and resistors to prescription of new FDCs ... Pay-Per-View - M2 Presswire - HighBeam Research

Worldwide Shortage of Glaxo's AIDS Drug, AZT, Alarms Patients, …  -  Nov 9, 2005
In GSK's case, it created Combivir a two-drug combination consisting of AZT and ... As a consequence GSK's Combivir drove down demand for its older single ... RedOrbit

La combinación de Truvada y efavirenz mejora el control en VIH  -  Jan 15, 2008
La causa más frecuente de interrupción con Combivir fue anemia/descenso de la hemoglobina. La irritación cutánea fue la causa más frecuente en el caso de ... Dmedicina

HN77 VS: zwendel met Combivir  -  Jul 10, 2007
In de VS zijn verpakkingen Combivir opgedoken die geen Combivir bleken te bevatten maar abacavir. Volgens de fabrikant van zowel Combivir als abacavir, GSK, ... Hiv Vereniging Nederland

Once-daily pill could simplify HIV treatment  -  Feb 6, 2006
Researchers compared its effectiveness to that of the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. ... 中国日报 - 中国日报

Press Release: Epidemiology Study Reports New Information on …  -  Jul 26, 2005
Article: Simple and Compact Ziagen/Combivir Regimen Results in . ... Further, one study evaluated adherence to Ziagen/Combivir compared to the PI-containing ... Pay-Per-View - PR Newswire - HighBeam Research

Truvada® aura-t-il la peau de Combivir ?  -  Mar 5, 2006
Dans le monde de l'industrie pharmaceutique, la bataille pour la suprématie bat son plein. Et ce n'est pas nouveau... Faute de réelle nouveauté à court ... survivreausida.net

HN76 Dilemma's bij preventie moeder-kindoverdracht  -  Jul 10, 2007
Naar de behandeling met Combivir is door het IATEC in de Petra-trial ... De trial vergeleek drie verschillende Combivir-behandelingen met placebo bij 1800 ... Hiv Vereniging Nederland

Netherlands Corporate News - Amerikaanse Food and Drug …  -  Dec 7, 2006
This difference largely results from the higher number of discontinuations in the Combivir/SUSTIVA group due to adverse events (9% vs. ... Netherlands Corporate News - Netherlands Corporate News (persbericht)

Forte opposizione al brevetto su un farmaco contro l'AIDS in India: è...  -  Mar 30, 2006
La disponibilità di versioni generiche di qualità a prezzi accessibili del Combivir (AZT/3TC) e di altri farmaci antiretrovirali ha consentito ai paesi in ... Medici Senza Frontiere

HIV Regimen With Fourth Drug Doesn't Improve Results  -  Aug 13, 2006
Usually, these subjects received Glaxo's Combivir pill plus New York-based Bristol-Myers's ... Combivir is a combination of Glaxo's AZT and Epivir drugs. ... Bloomberg

Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine …  -  Oct 17, 2007
Through 48 weeks, 84 percent of patients in the Viread/Emtriva/SUSTIVA group (n=244) compared to 73 percent of patients in the Combivir/SUSTIVA group ... Genetic Engineering News - Genetic Engineering News (press release)

Door Hiv Vereniging Nederland  -  Jul 10, 2007
Er werd in Parijs een kleine studie gepresenteerd waarin Combivir + efavirenz ... Als de laatste combinatie inderdaad slechter blijkt te zijn dan Combivir + ... Hiv Vereniging Nederland

AIDS baby drug dispute  -  Apr 8, 2005
Studies show adding a drug called Combivir to the nevirapine dose ... Combivir, made by GlaxoSmithKline Plc, contains two HIV drugs called AZT and 3TC. ... TVNZ

Gilead expects to increase share of HIV market  -  Feb 23, 2006
L: Quote, Profile, Research, Stock Buzz) Combivir. ... Combivir we saw both safety and efficacy advantages," Martin said. Over just the last 18 months, ... Reuters





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy